165 related articles for article (PubMed ID: 16902895)
1. [Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients].
Krammer HJ; Kämper H; von Bünau R; Zieseniss E; Stange C; Schlieger F; Clever I; Schulze J
Z Gastroenterol; 2006 Aug; 44(8):651-6. PubMed ID: 16902895
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
Plassmann D; Schulte-Witte H
Med Klin (Munich); 2007 Nov; 102(11):888-92. PubMed ID: 17992479
[TBL] [Abstract][Full Text] [Related]
3. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.
Henker J; Laass M; Blokhin BM; Bolbot YK; Maydannik VG; Elze M; Wolff C; Schulze J
Eur J Pediatr; 2007 Apr; 166(4):311-8. PubMed ID: 17287932
[TBL] [Abstract][Full Text] [Related]
4. The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial.
Tromm A; Niewerth U; Khoury M; Baestlein E; Wilhelms G; Schulze J; Stolte M
Z Gastroenterol; 2004 May; 42(5):365-9. PubMed ID: 15136935
[TBL] [Abstract][Full Text] [Related]
5. Probiotics, prebiotics, and synbiotics.
de Vrese M; Schrezenmeir J
Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
[TBL] [Abstract][Full Text] [Related]
6. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.
Henker J; Laass MW; Blokhin BM; Maydannik VG; Bolbot YK; Elze M; Wolff C; Schreiner A; Schulze J
Pediatr Infect Dis J; 2008 Jun; 27(6):494-9. PubMed ID: 18469732
[TBL] [Abstract][Full Text] [Related]
7. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.
Henker J; Müller S; Laass MW; Schreiner A; Schulze J
Z Gastroenterol; 2008 Sep; 46(9):874-5. PubMed ID: 18810672
[TBL] [Abstract][Full Text] [Related]
8. Probiotics and functional gastrointestinal disorders in children.
Vandenplas Y; Benninga M
J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
[TBL] [Abstract][Full Text] [Related]
9. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
Schultz M; Watzl S; Oelschlaeger TA; Rath HC; Göttl C; Lehn N; Schölmerich J; Linde HJ
J Microbiol Methods; 2005 Jun; 61(3):389-98. PubMed ID: 15767015
[TBL] [Abstract][Full Text] [Related]
10. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study.
Bekkali NL; Bongers ME; Van den Berg MM; Liem O; Benninga MA
Nutr J; 2007 Aug; 6():17. PubMed ID: 17683583
[TBL] [Abstract][Full Text] [Related]
11. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
Dughera L; Elia C; Navino M; Cisarò F;
Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.
Zyrek AA; Cichon C; Helms S; Enders C; Sonnenborn U; Schmidt MA
Cell Microbiol; 2007 Mar; 9(3):804-16. PubMed ID: 17087734
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo.
Enck P; Zimmermann K; Menke G; Klosterhalfen S
Z Gastroenterol; 2009 Feb; 47(2):209-14. PubMed ID: 19197823
[TBL] [Abstract][Full Text] [Related]
14. Probiotics and gastrointestinal diseases.
Sullivan A; Nord CE
J Intern Med; 2005 Jan; 257(1):78-92. PubMed ID: 15606379
[TBL] [Abstract][Full Text] [Related]
15. Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study.
Bär F; Von Koschitzky H; Roblick U; Bruch HP; Schulze L; Sonnenborn U; Böttner M; Wedel T
Neurogastroenterol Motil; 2009 May; 21(5):559-66, e16-7. PubMed ID: 19220758
[TBL] [Abstract][Full Text] [Related]
16. Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs.
Duncker SC; Lorentz A; Schroeder B; Breves G; Bischoff SC
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):239-50. PubMed ID: 16530848
[TBL] [Abstract][Full Text] [Related]
17. Critical evaluation of probiotic activity of lactic acid bacteria and their effects.
Heczko PB; Strus M; Kochan P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():5-12. PubMed ID: 17242483
[TBL] [Abstract][Full Text] [Related]
18. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
[TBL] [Abstract][Full Text] [Related]
19. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
20. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy.
Szajewska H; Setty M; Mrukowicz J; Guandalini S
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):454-75. PubMed ID: 16707966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
